Physician
Podhorzer, Joseph
Podhorzer, Joseph was paid $281K by Medicaid between Jan 2018 and Oct 2024, across 22 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 53% of everything it billed.
33Billing provider infoPODHORZER, JOSEPH
BROOKLYN, NY 11229
BROOKLYN, NY 11229
33aNPI1073515847assigned 08/11/2005
33bProvider typeOphthalmology Physician
28Total paid$281K
24GClaims8,666
24DCodes billed22
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Ophthalmology Physician providers in New York
Rank by total paid#244 of 1,085
Median peer was paid$34K
This provider vs. median8.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,125 | $31K | |
| 2019 | 1,204 | $23K | |
| 2020 | 625 | $28K | |
| 2021 | 1,440 | $69K | |
| 2022 | 1,455 | $86K | |
| 2023 | 818 | $14K | |
| 2024incomplete | 999 | $31K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 53% | 427 | 394 | $150K |
| 67028 | Intravitreal injection of a pharmacologic agent | 16% | 1,671 | 1,548 | $46K |
| 92134 | 10% | 2,646 | 2,540 | $29K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 8.1% | 575 | 567 | $23K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.8% | 433 | 414 | $8K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.8% | 224 | 219 | $8K |
| 92226 | 2.5% | 645 | 556 | $7K | |
| J9035 | Injection, bevacizumab, 10 mg | 1.6% | 219 | 206 | $5K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.2% | 107 | 97 | $3K |
| 92202 | <1% | 547 | 532 | $2K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 13 | 13 | $841.46 |
| 92250 | <1% | 38 | 37 | $422.07 |
10 more codes
| 92225 | <1% | 15 | $295.72 | |
| 92201 | <1% | 16 | $47.69 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 413 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 15 | $0.00 |
| G9974 | Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity | 0% | 84 | $0.00 |
| 1036F | 0% | 177 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 302 | $0.00 |
| 4177F | 0% | 64 | $0.00 | |
| 2019F | 0% | 22 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.